Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. Show more
Rue Edouard Belin 12, Mont-Saint-Guibert, 1435, Belgium
Market Cap
136.5M
52 Wk Range
$3.05 - $11.87
Previous Close
$3.06
Open
$3.06
Volume
1,579
Day Range
$3.06 - $3.18
Enterprise Value
131.8M
Cash
22.48M
Avg Qtr Burn
-20.49M
Insider Ownership
37.04%
Institutional Own.
21.52%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|